SEREX analysis of gastric cancer antigens

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  2000-07-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/PL00014048PMID 10950146
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1

  1999cited by this paper
• A Novel Cytoplasmic Protein with RNA-binding Motifs Is an Autoantigen in Human Hepatocellular Carcinoma

  1999cited by this paper
• Role of amplified genes in the production of autoantibodies.

  1999cited by this paper
• Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3.

  1998cited by this paper
• Characterization of human colon cancer antigens recognized by autologous antibodies

  1998cited by this paper
• E-cadherin germline mutations in familial gastric cancer

  1998cited by this paper
• A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T Lymphocytes

  1998cited by this paper
• A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

  1998cited by this paper
• Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library.

  1998cited by this paper
• Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

  1998cited by this paper
• Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

  1998cited by this paper
• Prevalence of antibodies against proteins derived from leukemia cells in patients with chronic myeloid leukemia.

  1998cited by this paper
• Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens.

  1998cited by this paper
• Serological analysis of human tumor antigens: molecular definition and implications.

  1997cited by this paper
• Human tumor antigens recognized by T-cells

  1997cited by this paper
• Serological identification of human tumor antigens.

  1997cited by this paper
• Molecular Definition of a Novel Human Galectin Which Is Immunogenic in Patients with Hodgkin's Disease*

  1997cited by this paper
• Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma.

  1997cited by this paper
• T cell defined tumor antigens.

  1997cited by this paper
• A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

  1996cited by this paper
• The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40.

  1996cited by this paper
• A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

  1995cited by this paper
• Human neoplasms elicit multiple specific immune responses in the autologous host.

  1995cited by this paper
• Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

  1994cited by this paper
• Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.

  1994cited by this paper
• Cadherins in cancer: implications for invasion and metastasis.

  1993cited by this paper
• The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot.

  1992cited by this paper
• Cadherins.

  1992cited by this paper
• A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

  1991cited by this paper
• Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma.

  1987cited by this paper
• Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture.

  1981cited by this paper

• Autoantibodies as biomarkers for breast cancer diagnosis and prognosis

  2022cites this paper
• Identification of antibody against wingless‑type MMTV integration site family member 7B as a biliary cancer tumor marker.

  2022cites this paper
• Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment

  2019cites this paper
• Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades

  2016cites this paper
• Tumor‐associated autoantibody signature for the early detection of gastric cancer

  2013cites this paper
• induces spontaneous humoral and cellular immune responses NY-ESO-1 is highly expressed in poor prognosis multiple myeloma and

  2013cites this paper
• PASD1: A Promising Target for the Immunotherapy of Haematological

  2013cites this paper
• Innate Immune Regulation and Cancer Immunotherapy

  2012cites this paper
• A novel cancer/testis antigen KP-OVA-52 identified by SEREX in human ovarian cancer is regulated by DNA methylation

  2012cites this paper
• Genetic materials at the gene engineering division, RIKEN BioResource Center.

  2010cites this paper
• Applying bioinformatics for antibody epitope prediction using affinity-selected mimotopes – relevance for vaccine design

  2010cites this paper
• Cancer/testis (CT) antigens: Potential targets for immunotherapy

  2009cites this paper
• Targeting the immune system in cancer.

  2009cites this paper
• Role of CAGE, a novel cancer/testis antigen, in various cellular processes, including tumorigenesis, cytolytic T lymphocyte induction, and cell motility.

  2008cites this paper
• Identifikation von Antigenen eines großzelligen Medulloblastoms mittels der autologen serologischen Analyse einer Tumor cDNA-Expressionsbibliothek (SEREX)

  2006cites this paper
• Immunotheranostics: breaking tolerance in immunotherapy using tumor autoantigens identified on protein microarrays.

  2006cites this paper
• Antigens recognized by autologous antibodies of patients with soft tissue sarcoma.

  2005cites this paper
• Identification of specific autoantigens in Sjögren's syndrome by SEREX

  2005cites this paper
• Cancer Immunity, Vol. 5, p. 4 (4 March 2005)

  2005cites this paper
• NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses.

  2005cites this paper
• Autologous Adjuvant Linked Fibroblasta Induce Anti-Glioma Immunity: Implications for Development of a Glima Vaccine

  2004cites this paper
• Perspectives of SEREX-defined antigens in diagnosis and immunotherapy for gastric cancer

  2004cites this paper
• Identifizierung Hodgkin assoziierter Antigene mittels SEREX

  2004cites this paper
• Discovery and Immunologic Validation of New Antigens for Therapeutic Cancer Vaccines

  2004cites this paper
• Autologous adjuvant linked fibroblasts induce anti-glioma immunity: implications for development of a glioma vaccine

  2003cites this paper
• Toward a more complete recognition of immunoreactive antigens in squamous cell lung carcinoma

  2002cites this paper
• Analysis of the B‐cell repertoire against antigens expressed by human neoplasms

  2002cites this paper
• Tumor-infiltrating B lymphocytes as a potential source of identifying tumor antigen in human lung cancer.

  2002cites this paper
• Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.

  2002cites this paper
• Dendritic cells and tumor immunity.

  2001cites this paper